Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Divestments (2020 - 2021)

Standard Biotools (LAB) has disclosed Divestments for 2 consecutive years, with -$682000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Divestments fell 106.9% to -$682000.0 in Q4 2021 year-over-year; TTM through Sep 2022 was -$682000.0, a 105.74% decrease, with the full-year FY2021 number at $1.3 million, down 93.73% from a year prior.
  • Divestments was -$682000.0 for Q4 2021 at Standard Biotools, down from $2.0 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $11.2 million in Q3 2020 to a low of -$682000.0 in Q4 2021.